NCT00242294View on ClinicalTrials.gov

Efficacy and Safety of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-06)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

570

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

September 30, 2006

Study Completion Date

March 31, 2007

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DRUG

Roflumilast

Trial Locations (1)

Unknown

Nycomed Japan and Mitsubishi Tanabe Oharma Corporation, Osaka

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
collaborator

Mitsubishi Tanabe Pharma Corporation

INDUSTRY

lead

AstraZeneca

INDUSTRY